WE studied the effect of the cyclooxygenase (COX)-2 inhibitor nimesuli
de on experimental allergic neuritis (EAN). In rats fed with nimesulid
e starting on day 1 post inoculation, the clinical EAN score was signi
ficantly lower and the maximal clinical score was reduced compared wit
h the control group. Even if given after the onset of clinical signs,
the clinical score was reduced and improvement was faster than the con
trol group. Nimesulide inhibited decreases in weight in the experiment
al group. The histopathological observations of the sciatic nerve show
ed a decreased incidence of degenerated nerve fibers in the experiment
al group. Although the exact mechanism of its efficacy is not clear, a
COX-2 inhibitor may have potential as an additional therapeutic agent
in human inflammatory neuropathies. NeuroReport 9: 2331-2334 (C) 1998
Rapid Science Ltd.